• 1
    Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori–induced inflammation . Gastroenterology 1992; 102: 720 7.
  • 2
    Malfertheiner P & Miehlke S. Helicobacter pylori infection in ulcer pathogenesis. Digestion 1997; 58: 17 20.
  • 3
    Buckley M & O’Morain C. Helicobacter pylori and gastric cancer. Eur J Cancer Prev 1995; 4: 139 44.
  • 4
    Ricci C, Gatta L, Miglioli M, Vaira D. Therapeutic news on Helicobacter pylori from Budapest and Wien. Ital J Gastroenterol Hepatol 1998; 30: 648 62.
  • 5
    The European Helicobacter pylori Study Group . Current European concepts in the management of Helicobacer pylori infection. The Maastricht Consensus Report. Gut 1997; 41: 8 13.
  • 6
    Rinaldi V, Zullo A, De Francesco V, et al. Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy. Aliment Pharm Ther 1999; 13: 163 8.
  • 7
    Zullo A, Rinaldi V, Pugliano F, Diana F, Attili AF. Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: a randomized, prospective study. Am J Gastroenterol 1997; 92: 2029 31.
  • 8
    Tursi A, Cammarota G, Montalto M, et al. Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10: 285 8.
  • 9
    Spinzi GC, Bierti L, Bortoli A, et al. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998; 12: 433 8.
  • 10
    Catalano F, Catanzaro R, Bentivegna C, et al. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer. Aliment Pharmacol Ther 1998; 12: 59 62.
  • 11
    Bigard MA, Delchier JC, Riachi G, et al. One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin. Aliment Pharmacol Ther 1998; 12: 383 8.
  • 12
    Delchier JC, Elamine I, Goldfain D, et al. Omeprazole–amoxycillin versus omeprazole–amoxycillin–clarithromycin in the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1995; 10: 263 8.
  • 13
    Neville PM, Everett S, Langworthy H, et al. The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen. Aliment Pharmacol Ther 1999; 13: 497 501.
  • 14
    Svoboda P, Kantorova I, Ochmann J, et al. Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial. Hepato-Gastroenterol 1997; 44: 886 90.
  • 15
    Forné M, Viver JM, Esteve M, et al. Randomized clinical trial comparing two one-week triple therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing. Am J Gastroenterol 1998; 93: 35 8.
  • 16
    Schwartz H, Krause R, Sahba B, et al. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Am J Gastroenterol 1998; 93: 584 90.
    Direct Link:
  • 17
    Lee JM, Breslin NP, Hide DK, et al. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice. Aliment Pharmacol Ther 1999; 13: 489 96.
  • 18
    Moayyedi P, Sahay P, Tompkins D, Axon ATR. Efficacy and optimum dosage of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7: 835 40.
  • 19
    Van der Hulst RWM & Van’T Hoff BWM. Treatment of Helicobacter pylori eradication failure. Gastroenterol Int 1997; 10: 153 60.
  • 20
    Rinaldi V, Zullo A, Pugliano F, Valente C, Diana F, Attili AF. The management of failed dual or triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 1997; 11: 929 33.
  • 21
    Deltenre M, Ntounda R, Jonas C, De Koster E. Eradication of Helicobacter pylori: why does it fail? Ital J Gastroenterol Hepatol 1998; 30(Suppl. 3): S326 8.
  • 22
    Kashimura H, Suzuki K, Hassan M, et al. Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection. Aliment Pharmacol Ther 1999; 13: 483 7.
  • 23
    Masoero G, Della Monica P, Lombardo L, et al. Prevalence of H. pylori Infection and Eradication Treatment Results in a Consecutive Outpatients Series Referring to GI Units. ACG 64th Annual Scientific Meeting, 18–20 October 1999: 382 (Abstract).
  • 24
    Moschkowitz FM, Peled Y, Santo M, et al. High Helicobacter pylori numbers are associated with low eradication rate after triple therapy. Gut 1995; 36: 845 7.
  • 25
    Cole SP, Cirillo D, Kagnoff MF, Guiney DG, Eckmann L. Coccoid and spiral Helicobacter pylori differ in their abilities to adhere to gastric epithelial cells and induce Interleukin-8 secretion. Infec Immun 1997; 65: 843 6.
  • 26
    Benaissa M, Babin P, Quellard N, Pezennec L, Cenatiempo Y, Fauchere JL. Changes in Helicobacter pylori ultrastructure and antigens during conversion from the bacillary to the coccoid form. Infec Immun 1996; 64: 2331 5.
  • 27
    Zullo A, Rinaldi V, Hassan C, Festuccia F, Lauria V, Attili AF. Different Helicobacter pylori eradication rates between non-ulcer dyspepsia and peptic ulcer patients. Gut 1998; 43(Suppl. 3): A92A92(Abstract).
  • 28
    Schimd CH, Ross SD, Witing GW, Cory D, Chalmers TC. Omeprazole plus antibiotics in the eradication of H. pylori infection: a meta regression. Gut 1996; 39(Suppl. 2): A37A37(Abstract).